Caxton Associates (New York)’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,307
Closed -$777K 589
2024
Q1
$777K Sell
20,307
-42,106
-67% -$1.37M 0.04% 263
2023
Q4
$1.95M Buy
+62,413
New +$2.24M 0.1% 128
2020
Q3
Sell
-23,796
Closed -$1.46M 506
2020
Q2
$1.46M Buy
+23,796
New +$972K 0.13% 59

Other funds holding STAA

Caxton Associates (New York)'s STAA Position: Q2 2024 in Review

Caxton Associates (New York) sold out of STAAR Surgical (STAA) in Q2 2024, closing a stake of 20,307 shares — an estimated $777K sold.

Caxton Associates (New York) first reported a position in STAA in Q2 2020 and held it in 3 quarters. The position peaked at $1.95M in Q4 2023. 223 funds tracked by Wall St. Rank hold STAA as of Q2 2024.

  • Caxton Associates (New York) reported no remaining STAAR Surgical position as of Q2 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 20,307 STAAR Surgical shares in Q2 2024, an estimated $777K.
  • Caxton Associates (New York) first reported a position in STAAR Surgical in Q2 2020 and held it in 3 quarters.
  • Caxton Associates (New York)'s STAAR Surgical position peaked at $1.95M in Q4 2023.
  • 223 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2024.

Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.